Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Balversa is an innovative targeted therapy that effectively inhibits the growth ···【more】
Release date：2024-08-26Recommended：315
Balversa, a new targeted anti-cancer drug, provides new treatment hope for patie···【more】
Release date：2024-08-26Recommended：276
Balversa is a novel targeted anti-cancer drug that inhibits the FGFR signaling p···【more】
Release date：2024-08-26Recommended：239
Balversais an oral, targeted anti-cancer drug that specifically inhibits the FGF···【more】
Release date：2024-08-26Recommended：313
Balversais an oral anticancer drug targeting FGFR mutations for the treatment of···【more】
Release date：2024-08-26Recommended：331
Balversais a new oral anti-cancer drug targeting FGFR, which is specially design···【more】
Release date：2024-08-26Recommended：306
Balversais an oral tyrosine kinase inhibitor for the treatment of non-small cell···【more】
Release date：2024-08-26Recommended：271
Alpelisib has demonstrated a unique efficacy against PIK3CA mutations in HR/HER2···【more】
Release date：2024-08-23Recommended：314
Patients with HR/HER2- advanced breast cancer harboring PIK3CA mutations were si···【more】
Release date：2024-08-23Recommended：409
By specifically inhibiting PIK3CA mutations, Apelis provides a novel therapeutic···【more】
Release date：2024-08-23Recommended：352
Alpelisib fills a gap in the treatment of HR/HER2- breast cancer, particularly i···【more】
Release date：2024-08-23Recommended：336
For patients with advanced HR/HER2- breast cancer, the combination of Alpelisib ···【more】
Release date：2024-08-23Recommended：275
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
